New member | YouCie
After an overview of the mechanisms of the pharmacy and the problems encountered by the pharmacist and the patient, YouCie... View Article
New member | Abcely
Abcely’s mission is to develop new innovative medical and pharmaceutical technologies in the field of the treatment of mucosal cancers,... View Article
XENOTHERA announces the efficacy of its XAV-19 antibody against the BQ.1.1 variant
In the context of a major resurgence of the COVID epidemic, the French biotech XENOTHERA has just carried out an... View Article
Naobios signs a Research License Agreement with Valneva on EB66® cell line
Naobios announced the signature of a Research License Agreement with Valneva to assess the EB66® cell line as cell substrate for the evaluation... View Article
OSE Immunotherapeutics receives €10 Million
This financing will further support the progress and expansion of OSE Immunotherapeutics’ lead clinical development programs in therapeutic areas with... View Article
New member | Lyv Healthcare
At the root of Lyv, there is the patient’s reality, from women suffering from endometriosis. Women, who had to go... View Article
XAV-19: end of EUROXAV clinical trial and positive trends for the XENOTHERA antibody
Nantes-based biotech XENOTHERA, which develops innovative antibodies in several therapeutic areas, has developed XAV-19, an anti-COVID treatment based on its... View Article
New member | HPR Solutions
HPR solutions develops and sales soft mobility solutions called the Urbaner range: 3 electrically assisted tricycles, one of which is... View Article
New member | Où suis-je
Où suis-je is an innovative start-up created by Denis TROCH and Dominique MAGUER in March 2022, which offers an application... View Article
New member | MedSynApps
Founded in France in 2017, MedSynApps provides a full range of consulting and development services for the medical and enterprise... View Article